GlobeStar Therapeutics (GSTC) Short Interest Ratio & Short Volume

Short interest is the volume of GlobeStar Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 36,500 shares of GSTC short. Learn More on GlobeStar Therapeutics' current short interest.

GlobeStar Therapeutics saw a decline in short interest in April. As of April 30th, there was short interest totaling 36,500 shares, a decline of 51.5% from the previous total of 75,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to GlobeStar Therapeutics: RespireRx Pharmaceuticals Inc. (0.01%), Comera Life Sciences Holdings, Inc. (2.38%), Evelo Biosciences, Inc. (2.11%), SciSparc Ltd. (4.18%), China SXT Pharmaceuticals, Inc. (2.63%), Aditxt, Inc. (8.48%), Aptevo Therapeutics Inc. (16.76%), Sunshine Biopharma, Inc. (29.84%), Nexien BioPharma, Inc. (0.04%), Skinvisible, Inc. (0.05%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

Short selling GSTC is an investing strategy that aims to generate trading profit from GlobeStar Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for GlobeStar Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GSTC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GSTC, twice per month. The most recent reporting period available is April, 30 2024.